Table 1. Baseline demographic and clinical characteristics of the patients.

Baseline characteristics	PRN group	Fixed regimen group (loading phase+2q8)	P-value
Number of patients	36 (50%)	36 (50%)	1.0
Median age (range)	79 (59–93)	77 (52–85)	0.17
Gender	19 F (53%)–17 M (47%)	14 F (39%)/22 M (61%)	0.34
Median number of previous ranibizumab injections (n, 95% CI)	5 (4.5–7.5)	6.5 (4–9.5)	0.78
Median time of CNV diagnosis (months, 95% CI)	18 (14–24)	22 (11–31)	0.71
CNV type	C: 10 (28%), O: 26 (72%)	C: 14 (39%), O: 22 (61%)	0.21
	PED: 13 (36%)	PED 20 (56%)	0.15

Abbreviations: C, classic; CNV, choroidal neovascularization; fixed regimen, loading phase+bimonthly injections; O, occult; PED, pigment epithelium detachment; PRN, pro re nata strategy.